AZTA Stock Recent News
AZTA LATEST HEADLINES
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q4 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Sara Silverman - Head of IR Steve Schwartz - President and CEO Herman Cueto - CFO Conference Call Participants David Saxon - Needham Jacob Johnson - Stephens Andrew Cooper - Raymond James Paul Knight - KeyBanc Vijay Kumar - Evercore ISI Yuan Zhi - B. Riley Operator Thank you, and welcome to the Azenta Q4 2023 Financial Results.
Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $500 million in stock in fiscal 2024. The company — whose products and services help researchers store, handle and process chemical and biological samples — reported net income of $3.4 million, or 6 cents a share, compared with a loss of $20.8 million, or 28 cents a share, in the same quarter last year.
Azenta, Inc., formerly Brooks Automation, sold its semiconductor business and subsequently became a pure play life science business. Azenta's shares have declined significantly and its valuation is still supported by net cash holdings. However, Azenta is not profitable, making it difficult to be optimistic about its shares.
Having activist investors at a company can lead to big changes. Azenta is dealing with an activist's call for better performance as it puts a giant cash hoard to work.
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY, on Wednesday, September 13, 2023, which includes a presentation beginning at 2:55 pm ET.
BURLINGTON, Mass. , Sept. 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New York, NY, on Tuesday, September 12, 2023, which includes a presentation beginning at 9:05 am ET.
Today, we take our second look at a life sciences concern called Azenta, Inc. The company has a massive cash hoard, is buying back a huge amount of stock, but sales growth is slowing, and valuations appear stretched even after a recent pullback. An updated investment analysis around Azenta, Inc. follows in the paragraphs below.
Azenta, Inc. (NASDAQ:AZTA ) Q2 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Sara Silverman - Head, IR & Corporate Communications Stephen Schwartz - CEO, President & Director Lindon Robertson - EVP & CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Vijay Kumar - Evercore ISI David Saxon - Needham & Company Jacob Johnson - Stephens Inc. Yuan Zhi - B. Riley Securities Operator Greetings, and welcome to the Azenta Q2 2023 Financial Results.